GLOX THERAPEUTICS LIMITED
Company number SC760230 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£4,260,160
Balance sheet as at 2025-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2023-02-27
- Employees
- 10 (2025 accounts)
- Registered office
- John Arbuthnott Building Strathclyde University Of Pharmacy & Biomedical, 161 Cathedral Street, Glasgow, Scotland, G4 0RE
- Postcode
- G4 0RE
- Capital
- 186 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-02-26
- Next due by
- 2027-03-12
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
- 72190 Other research and experimental development on natural sciences and engineering
Officers 2 current · 5 resigned
Subscribers only
Director
Subscribers only
Director
Data protection registration
Registered with the ICO as a data protection fee payer — ZB566925 (Tier 1), registered since 2023.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Among its peers
Top 10%
by shareholders' funds, of 42 similar companies in G
Trading since 2023.
No.3 of the largest research and experimental development on biotechnology companies in Glasgow →
Competitors Glasgow
This company ranks 3 among research and experimental development on biotechnology in Glasgow.